Clinical Trials Directory

Trials / Completed

CompletedNCT00663351

Safety and Effectiveness Study of the Reflection Ceramic Acetabular System

Post Approval Study: Reflection Ceramic Acetabular System

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
456 (actual)
Sponsor
Smith & Nephew, Inc. · Industry
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This Post-Approval study is prospective follow-up study designed to evaluate the long-term safety and effectiveness of the Reflection Ceramic Acetabular System.

Detailed description

This Post-Approval study is prospective follow-up study designed to evaluate the long-term safety and effectiveness of the Reflection Ceramic Acetabular System. Randomized Non-inflammatory Arthritis, Randomized Inflammatory and Continued Access Cohorts patients previously enrolled in the IDE study will be evaluated annually through five (5) year follow-up. In addition, all patients enrolled in the original study cohorts as well as the continued access patients will be sent a letter questionnaire annually at the 6-10 year postoperative time point to assess the patient's general well-being and if the study components are still in place

Conditions

Interventions

TypeNameDescription
DEVICEReflection Ceramic-Ceramic Total Hip ReplacementIntervention: all patients in study required (intervention) a total hip replacement, and were randomized to receive either the (Study Device)Reflection Ceramic Acetabular System or the(Control Device) Reflection FSO V (5 hole)acetabular system. Both arms received either a Synergy porous coated or Spectron EF stem.
DEVICEReflection FSO V Total Hip ReplacementIntervention: all patients in study required (intervention) a total hip replacement, and were randomized to receive either the (Study Device)Reflection Ceramic Acetabular System or the(Control Device) Reflection FSO V (5 hole)acetabular system. Both arms received either a Synergy porous coated or Spectron EF stem.

Timeline

Start date
2004-12-01
Primary completion
2014-10-01
Completion
2014-12-01
First posted
2008-04-22
Last updated
2022-10-13
Results posted
2022-10-13

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00663351. Inclusion in this directory is not an endorsement.